August 12, 2026 - 17:22

OpenAI and other major tech companies are moving fast to define how artificial intelligence fits into everyday life. But there is a growing question that is hard to ignore: why are a handful of private firms making the biggest social and political decisions about this technology without a broader public conversation?
The core issue is not whether AI is useful. It clearly is. The problem is who sets the limits, who decides what is safe, who gets access, and who profits. Right now, those answers come from corporate boardrooms, not from citizens or their elected representatives. That is a serious imbalance.
Tech leaders often frame AI as an unstoppable force, something we must adapt to quickly or be left behind. That framing is convenient for them. It makes their choices look like natural progress rather than business strategy. But AI is not a weather system. It is a tool built by people, with specific goals and trade-offs. We can shape it, but only if we stop treating corporate roadmaps as destiny.
There are real choices to make. Should AI be used in hiring, healthcare, or policing? Should it be open source or locked down? Should it replace human judgment in critical areas or only assist it? These are not technical questions. They are value judgments, and they belong to everyone.
The industry will not hand over that control willingly. It will take regulation, public pressure, and a serious shift in how we talk about innovation. The future of AI is too important to leave to a few companies that answer to shareholders. It is time to take the narrative back and decide together what kind of society we actually want to build.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...